Clinical Trial Update: Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing MK-0974 to placebo for acute migraine; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MK-0974

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraines | Phase 3 | Status: COMPLETED | Results posted: 2014-08-29